C4 THERAPEUTICS INC. - COMMON STOCK
5.3800
04-October-24 15:59:56
15 minutes delayed
Stocks
+0.0400
+0.75%
Today's range
5.1800 - 5.4800
ISIN
N/A
Source
NASDAQ
-
C4 Therapeutics Announces Pricing of Public Offering
16 Jun 2021 19:51:25 By Nasdaq GlobeNewswire
-
C4 Therapeutics Launches Proposed Public Offering
14 Jun 2021 16:12:23 By Nasdaq GlobeNewswire
-
14 Jun 2021 08:00:01 By Nasdaq GlobeNewswire
-
07 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Advance CFT8919, A Selective Degrader of EGFR L858R, Into IND-enabling Studies
26 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Lauren White as Chief Financial Officer
20 May 2021 16:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
13 May 2021 16:01:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Upcoming Investor Conferences
12 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
10 Apr 2021 15:05:00 By Nasdaq GlobeNewswire